Data can help healthcare providers make higher-value care decisions that result in improved quality outcomes and reduced costs; however, the way in which the data is presented plays a key role in its effectiveness. This presentation will report on a 90-day pilot study completed at Houston Methodist that explored how presenting clinical and financial data at the point of care could impact ordering behavior and facilitate cost-effective, quality clinical decision making. Led by the health system CMIO, the pilot consisted of 145 providers and 38 pharmacists. Providers were presented with an unobtrusive tool that offers real-time, patient-specific cost and select risk data for medications, labs, and radiology studies, along with seamless access to patients’ Texas Prescription Monitoring Program (PMP) reports. Providers also received context-specific alerts directly within their clinical workflow based on EHR, PMP, and clinical surveillance data. The organization was able to shift the cost curve within the 90-day mark.
Explain how presenting clinical and financial data to physicians at the point of care could impact ordering behavior and facilitate cost-effective, quality clinical decision making
Explain how the Provider Cost Transparency pilot used by Houston Methodist tested how integrating clinical alerts into its EMR workflow could help physicians and pharmacists make more cost-effective, higher-quality care decisions
Discuss how Houston Methodist is using clinical surveillance to support high-value care and describe the challenges faced when integrating clinical surveillance into the physician workflows
Analyze the ROI of the pilot study and the overall impact using integrated alerts had on shifting the cost curve and clinical practices
Describe the technology and tools used in the pilot to achieve the proposed clinical efficiencies and reduced cognitive burden for physicians